Clinical observation of tetrandrine tablets combined with celecoxib in treating knee osteoarthritis
10.3969/j.issn.1671-8348.2025.09.020
- VernacularTitle:汉防己甲素片联合塞来昔布治疗膝关节骨性关节炎的临床观察
- Author:
Ming JI
1
;
Junhua TAN
;
Jian CHEN
Author Information
1. 重庆大学附属三峡医院骨科中心,重庆 404000
- Keywords:
tetrandrine tablets;
celecoxib;
knee osteoarthritis;
clinical effect
- From:
Chongqing Medicine
2025;54(9):2112-2116
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical efficacy of tetrandrine tablets combined with celecoxib in treating knee osteoarthritis(KOA).Methods A total of 234 patients with KOA admitted and treated in this hospital from February 2022 to January 2024 served as the study subjects.According to the random num-ber table method,the patients were assigned into the single group and combination group,117 cases in each group.The single group was treated with celecoxib capsules,while the combination group was treated with tetrandrine tablets on the basis of the single group treatment.The Western Ontario and McMaster Universi-ties Osteoarthritis Index(WOMAC)score,Hospital for Special Surgery(HSS)score,visual analogue scale(VAS)score,inflammatory factor level,bone metabolism related indicators levels,clinical efficacy and adverse reactions before treatment(T0)and in 24 weeks after treatment(T1)were observed and compared between the two groups.Results At T1,the WOMAC score,VAS score,levels of interleukin-iβ(IL-1β),tumor necro-sis factor-α(TNF-α)and CTX-Ⅱ in the two groups were significantly decreased compared with those at T0,moreover the combination group was lower than the single group,and the differences were statistically signifi-cant(P＜0.001).The HSS score,serum osteoprotegerin(OPG)and fibroblast growth factor-2(FGF-2)lev-els in the two groups were significantly increased compared with those at T0,moreover the combination group was higher than the single group,and the differences were statistically significant(P＜0.001).At T1,the to-tal effective rate in the combination group was 89.74％,which was significantly higher than 77.78％in the single group,and the difference was statistically significant(P＜0.05).During the treatment period,the total incidence rate of adverse reactions in the combination group was 3.42％,which was significantly lower than 12.82％in the single group,and the difference was statistically significant(P＜0.05).Conclusion The clinical efficacy of tetrandrine tablets combined with celecoxib in treating KOA is prominent,it could effectively allevi-ate the joint pain,improve the inflammation and bone metabolism level of the patients,and has certain safety.
